hero background

ChondroFiller® at the Liquid Cartilage

Injectable, Structural Regenerative Implant for Cartilage Care

Protect • Repair • Regenerate

← Back Home
Understanding Knee Gel Injections: How Modern Injectable Therapies Support Osteoarthritis Management

Understanding Knee Gel Injections: How Modern Injectable Therapies Support Osteoarthritis Management

Introduction

Knee osteoarthritis is a common and often painful condition where the smooth cartilage cushioning the knee joint gradually wears away. This leads to symptoms such as pain, stiffness, swelling, and difficulty moving the knee. In the UK, millions are affected, making everyday tasks like walking or climbing stairs challenging for many. While surgery can help some, many people either are not ready for it or want to avoid invasive procedures. Fortunately, knee gel injections offer a non-surgical alternative that can relieve symptoms and improve mobility. In this article, we delve into what these injections are, how they work, who they help, and the evidence supporting their use.

What Are Knee Gel Injections?

Knee gel injections, often called viscosupplementation, involve injecting a gel-like substance directly into the knee joint. This gel works to replenish the natural lubricating fluid that tends to diminish as osteoarthritis progresses. The aim is to restore cushioning and smooth movement inside the joint.

There are mainly two types of gels used: hyaluronic acid and polyacrylamide hydrogel. Hyaluronic acid (HA) is a substance naturally found in joint fluid, helping to lubricate and cushion the knee. Polyacrylamide hydrogel, such as Arthrosamid, is a synthetic alternative that forms a lasting scaffold inside the joint to provide support and protection. Unlike steroid injections or other treatments, these gels focus on improving the joint’s environment, helping to reduce pain and stiffness without surgery.

How Do Gel Injections Work?

Hyaluronic acid injections top up the knee’s natural fluid, improving its ability to lubricate and absorb shocks. This may reduce pain and inflammation, providing relief for several months—usually up to six. However, HA is gradually broken down by the body and the effects diminish over time.

Polyacrylamide hydrogels are different. They are synthetic, non-biodegradable gels that stay longer inside the joint. Acting like a cushion, they help protect and support the cartilage and surrounding tissues. Clinical studies have shown that hydrogels like Arthrosamid can provide benefits lasting up to two years after a single injection.

Both options are generally safe, with few side effects. They complement other approaches in managing osteoarthritis and can play a valuable role in delaying or avoiding surgery.

Who Can Benefit, and What Should You Expect?

Knee gel injections are suitable for people with mild to moderate osteoarthritis who want to ease their symptoms without surgery. They may be especially helpful if you’re aiming to stay active or have found other treatments have not brought sufficient relief.

The process starts with a thorough assessment by a healthcare professional, often including scans like ultrasound or MRI to check the joint’s condition. The injection itself is usually quick and performed under local anaesthetic to minimise discomfort. Precise placement of the gel is important, often guided by ultrasound.

After the injection, you might feel mild swelling or stiffness, but most people can resume walking straight away. It’s advisable to avoid heavy exercise for a few days. Improvements typically begin within a few weeks and can last several months (or even years with hydrogels), helping you move more comfortably.

Expert Care and Support

Professor Paul Lee is a leading expert in cartilage health and orthopaedics based at the London Cartilage Clinic. With years of experience and a strong focus on evidence-based treatment, he provides patients with tailored care and expert advice on managing knee osteoarthritis.

Under his guidance, patients benefit from advanced treatments like gel injections combined with rehabilitation strategies, all delivered in a supportive and professional environment. Consulting a reputable specialist ensures your treatment is personalised and safe.

Evidence and Outcomes

Scientific studies support the role of gel injections in reducing pain and improving knee function. Hyaluronic acid injections usually offer relief for three to six months and are well tolerated by most patients.

Polyacrylamide hydrogel injections stand out for their longer-lasting effect—often up to two years after a single treatment—and their ability to provide cushioning and mechanical support inside the joint. Side effects are rare and generally mild.

It’s important to remember these injections do not regrow cartilage but are valuable in managing symptoms and may help delay the need for surgery. Research continues to refine these treatments and explore how best to combine them with other therapies for improved outcomes.

Conclusion and Important Advice

Knee gel injections are a safe and effective option for many people looking to manage osteoarthritis without surgery. By restoring lubrication and cushioning in the joint, they can reduce pain and enhance mobility, fitting into a broader treatment plan that includes exercise and lifestyle changes.

Always consult a qualified healthcare professional to discuss your symptoms and decide which treatment is right for you.

For individual medical advice, please consult a qualified healthcare professional.

References

  • Based on current clinical guidelines and expert consensus in orthopaedic care.

Frequently Asked Questions

  • Knee gel injections replenish natural joint lubrication, easing pain and stiffness for many months. At MSK Doctors, Prof Paul Lee employs advanced techniques, ensuring precise placement and tailored care for optimal results based on his extensive cartilage expertise and international reputation.
  • Ideal candidates are those with mild to moderate knee osteoarthritis seeking non-surgical symptom relief. Professor Paul Lee, a recognised cartilage expert, personally assesses all patients to determine suitability and tailors treatments to maximise comfort and movement while prioritising safety.
  • Prof Paul Lee is a global leader in cartilage health, holding key ambassador and advisory roles. At MSK Doctors, his evidence-based approach combines expert assessment, advanced technology, and individualised rehabilitation strategies in a professional environment, providing outstanding care and support throughout your treatment journey.
  • Hyaluronic acid injections often provide relief for three to six months, while polyacrylamide hydrogels may last up to two years. Under Prof Lee’s guidance at MSK Doctors, ongoing support and further strategies are available to help maintain improved knee function and comfort.
  • Knee gel injections are generally safe, with mild and infrequent side effects such as temporary stiffness. Prof Paul Lee’s experience ensures expert technique and careful patient monitoring, supporting a positive, safe experience for those choosing advanced non-surgical osteoarthritis management at MSK Doctors.

Next steps

Where to go from here

These routes are selected from the topic and purpose of this article. They are guidance, not a diagnosis or treatment recommendation.

Learn more

Explore osteoarthritis

Read the reviewed osteoarthritis pathway, including who it may help and what happens next.

Talk to the team

Book a free discovery call

A non-medical call with the team to understand services and choose the right booking route.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Liquid Cartilage. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Liquid Cartilage accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.
Patient recovering with guidance

Take the Next Step

Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.

At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.

  • Start with a Discovery Call.
  • Or book your Consultation with Prof. Lee today.

(Consultation fee credited towards treatment if you proceed.)

Verified by DoctifyVerified by Doctify

Latest Blog

View all →
Can ChondroFiller injection delay joint replacement?
08 Sept 2026

Can ChondroFiller injection delay joint replacement?

ChondroFiller injection can extend the window before joint replacement in patients with focal cartilage defects by delivering a Type I collagen scaffold that recruits progenitor cells to produce lasting repair tissue. Three-year data show sustained functional gains and over 80% defect filling on imaging.

ChondroFiller injection for hip OA with synovial support
08 Sept 2026

ChondroFiller injection for hip OA with synovial support

Advanced hip osteoarthritis involves two parallel pathologies: cartilage loss and synovial inflammation. The staged injection programme targets each separately — ChondroFiller enables endogenous cartilage repair via a collagen scaffold; Arthrosamid buffers the inflamed synovial lining.

Cartilage damage after ACL reconstruction
08 Sept 2026

Cartilage damage after ACL reconstruction

ACL reconstruction restores ligament stability but leaves cartilage damage untouched; the same pivot-shift injury that tears the ligament also compresses joint surfaces, initiating degeneration that typically appears 10–15 years later.

ChondroFiller injection for hip cartilage wear after 60
07 Sept 2026

ChondroFiller injection for hip cartilage wear after 60

ChondroFiller injection, delivered in a 30-minute ultrasound-guided outpatient session without general anaesthetic, recruits the patient's progenitor cells to repair hip cartilage over six to twelve months — a mechanism that works without high regenerative capacity, making age no barrier.

Why microfracture fades and ChondroFiller injection holds
07 Sept 2026

Why microfracture fades and ChondroFiller injection holds

Microfracture repairs cartilage defects with fibrocartilage—mechanically weaker tissue than healthy cartilage—which fatigues under joint loading around the two-year mark. ChondroFiller injection, by contrast, scaffolds tissue that continues to mature rather than declining.

Focal hip cartilage defect vs osteoarthritis
06 Sept 2026

Focal hip cartilage defect vs osteoarthritis

A focal hip cartilage defect is a discrete lesion with intact cartilage borders; osteoarthritis is diffuse wear across the entire joint with no healthy zones. Repair techniques depend on those intact borders as biological anchors — which is why they work for focal defects but fail in osteoarthritis.

Privacy & Cookies Policy